BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14602062)

  • 1. Extraintestinal complications of inflammatory bowel disease.
    Orchard T
    Curr Gastroenterol Rep; 2003 Dec; 5(6):512-7. PubMed ID: 14602062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
    He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
    Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Manifestations of Inflammatory Bowel Disease.
    Greuter T; Navarini A; Vavricka SR
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):413-427. PubMed ID: 28643285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important cutaneous manifestations of inflammatory bowel disease.
    Trost LB; McDonnell JK
    Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fleisher M; Marsal J; Lee SD; Frado LE; Parian A; Korelitz BI; Feagan BG
    Dig Dis Sci; 2018 Apr; 63(4):825-833. PubMed ID: 29484571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
    Barrie A; Regueiro M
    Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease.
    Annese V
    Saudi J Med Med Sci; 2019; 7(2):66-73. PubMed ID: 31080385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extradigestive manifestations of IBD in pediatrics.
    Aloi M; Cucchiara S
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():23-32. PubMed ID: 19530508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases.
    Reinshagen M; von Tirpitz C
    Dig Dis; 2003; 21(2):138-45. PubMed ID: 14571111
    [No Abstract]   [Full Text] [Related]  

  • 13. Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Peyrin-Biroulet L; Van Assche G; Gómez-Ulloa D; García-Álvarez L; Lara N; Black CM; Kachroo S
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):25-36.e27. PubMed ID: 27392760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease.
    Siemanowski B; Regueiro M
    Curr Treat Options Gastroenterol; 2007 Jun; 10(3):178-84. PubMed ID: 17547856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
    Apgar JT
    Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extraintestinal complications of inflammatory bowel disease].
    Kinjo F; Iraha A; Chinen H; Ihama Y; Kishimoto K; Hokama A
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():261-5. PubMed ID: 23126101
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease.
    Olpin JD; Sjoberg BP; Stilwill SE; Jensen LE; Rezvani M; Shaaban AM
    Radiographics; 2017; 37(4):1135-1160. PubMed ID: 28548906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Rogler G; Singh A; Kavanaugh A; Rubin DT
    Gastroenterology; 2021 Oct; 161(4):1118-1132. PubMed ID: 34358489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.